Maximilian Pfau, Carl Zeiss Meditec (F), Carl Zeiss Meditec (C), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Leon von der Emde, Carl Zeiss Meditec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Luis De Sisternes, Carl Zeiss Meditec Inc. (E);
Joelle Hallak, None;
Theodore Leng, None;
Steffen Schmitz-Valckenberg, Acucela (F), Alcon/Novartis (C), Alcon/Novartis (F), Alcon/Novartis (R), Allergan (C), Allergan (F), Allergan (R), Bayer (F), Bayer (R), Bioeq/Formycon (F), Carl Zeiss MedicTec (R), Carl Zeiss Meditec (F), CenterVue (F), Galimedix (C), Genentech/Roche (F), Heidelberg Engineering (F), Katairo (F), Optos (F);
Frank Holz, Acucela (C), Acucela (F), Allergan (C), Allergan (F), Appelis (C), Bayer (C), Bioeq/Formycon (C), Boehringer-Ingelheim (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec (R), CenterVue (F), Ellex (R), Geuder (C), Grayburg Vision (C), Heidelberg Engineering (F), Heidelberg Engineering (C), Kanghong (C), LinBioscience (C), NightStarX (F), Novartis (C), Optos (F), Oxurion (C), Pixium Vision (C), Roche/Genentech (C), Stealth BioTherapeutics (C);
Monika Fleckenstein, Carl Zeiss Meditec (F), CenterVue (F), Heidelberg Engineering (F), Novartis (F), Novartis (C), Ophthalmo Update GmbH (C), Optos (F), Roche/Genentech (C), STZ GRADE Reading Center (E), US20140303013A1 (P);
Daniel Rubin, None